JORDAN ORR: Open Payments
NPI 1184226888 · SEMMES, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$435 in 24 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $250 · 2025 $435
Food & beverage: $435
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $151 |
| ABBVIE INC. | 13 | $145 |
| Boston Scientific Corporation | 2 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: Wegovy, VRAYLAR, WATCHMAN Access System, QULIPTA, CAPLYTA, VOQUEZNA, REXULTI, Cologuard Collection Kit.
Industry payments across AL — which companies pay providers there.
